Understanding how new traits evolve in living organisms
Molecular Genetics of Evolutionary Innovations
This study is exploring how new traits develop in living things, like how certain genes work together, and it could help us understand more about the genetic factors behind chronic and infectious diseases that affect patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11031063 on NIH RePORTER |
What this research studies
This research investigates the origins of entirely new traits in living organisms, focusing on the molecular mechanisms behind evolutionary innovations. By studying various biological levels, from genes to complex structures, the project aims to uncover how these novelties arise and their significance in the diversity of life. The approach includes analyzing gene expression and regulatory pathways, particularly using model organisms like fruit flies. Patients may benefit from insights gained about genetic factors that contribute to chronic and infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with genetic disorders or chronic diseases that may be influenced by evolutionary genetic mechanisms.
Not a fit: Patients with acute conditions or those not affected by genetic factors may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of genetic factors that lead to new traits, potentially informing treatments for chronic and infectious diseases.
How similar studies have performed: While the study of evolutionary innovations is a relatively novel area, there have been successful research efforts in understanding gene evolution and its implications for health.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Kopp, Artyom — University of California at Davis
- Study coordinator: Kopp, Artyom
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.